[Consensus on the efficacy evaluation of HPV prophylactic vaccine clinical trials].
出版信息
Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):552-4.
PMID:24257312
Abstract
摘要
相似文献
1
[Consensus on the efficacy evaluation of HPV prophylactic vaccine clinical trials].
Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):552-4.
2
[In defence of women against HPV-infection].
Orv Hetil. 2007 Apr 29;148(17):813. doi: 10.1556/OH.2007.17B.
3
[Risk factors of cervical cancer and possibilities of primary prevention].
Przegl Epidemiol. 2011;65(1):81-8.
4
[Vaccine against human papillomavirus : PATRICIA Study (PApilloma TRIal against Cancer In young Adults)].
Internist (Berl). 2010 Mar;51(3):410, 412-3. doi: 10.1007/s00108-009-2575-8.
5
Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine.
Contemp Clin Trials. 2017 Jan;52:54-61. doi: 10.1016/j.cct.2016.10.006. Epub 2016 Oct 21.
6
[Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
Wiad Lek. 2007;60(1-2):34-8.
7
Human papillomavirus vaccine efficacy: aligning expectations with reality.
Gynecol Oncol. 2008 Oct;111(1):1-2. doi: 10.1016/j.ygyno.2008.09.001.
8
[What should be known for the introduction of an HPV vaccine?].
Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10.
9
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol. 2012 Jan;13(1):100-10. doi: 10.1016/S1470-2045(11)70287-X. Epub 2011 Nov 8.
10
Letter to the editor response to the article of Luisa Lina Villa HPV prophylactic vaccination: the first years and what to expect from now, in press.
Cancer Lett. 2011 May 1;304(1):70. doi: 10.1016/j.canlet.2011.01.024. Epub 2011 Feb 19.
Zotero 插件